{
  "id": "International_Prognostic_Index_for_Diffuse_Large_B_cell_Lymphoma_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-09-16",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict overall and progression-free survival in DLBCL based on risk factors.",
        "keywords": [
          "diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL)",
          "B-cell Lymphoma",
          "Prognostic "
        ],
        "use": "Use in in CD20+ DLBCL patients.\nNote:  IPI results are included for historical comparisons only. \n\nVariables and points: \n- Age ≤60=0, Age >60 years=1;\n- Ann Arbor stage: Stage I or II (localized disease)=0, Stage III or IV (advanced disease)=1 (III: Involvement on both sides of the diaphragm, IV: Involvement of extranodal sites);\n- ECOG performance status: 0 or 1=0, ≥2=1;\n- Serum LDH: ≤1× normal=0, >1× normal=1;\n- Extranodal sites: ≤1´0, >1´1. \nInterpretation: \n0 R-IPI = Very good prognosis= 4-year overall survival, 94 %= 4-year progression-free survival, 94 %;\n1-2 R-IPI= Good prognosis= 4-year overall survival, 79 %= 4-year progression-free survival, 80 %;\n3-5 R-IPI= Poor prognosis= 4-year overall survival, 55 %= 4-year progression-free survival, 53 %;\n0-1 IPI= Low risk group = 4-year overall survival, 82 %= 4-year progression-free survival, 85 %;\n2  IPI= Low-intermediate risk group = 4-year overall survival, 81 %= 4-year progression-free survival, 80 %;\n3  IPI= High-intermediate = 4-year overall survival, 49 %= 4-year progression-free survival, 57 %;\n4-5  IPI= High = 4-year overall survival, 59 %= 4-year progression-free survival, 51 %;\n\n\n",
        "misuse": "Not to use in patients with HIV, secondary malignancies, low grade lymphoproliferative disorders, or comorbidities precluding curative therapy attempt. \n",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987-94.\n2. Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109(5):1857-61."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "template_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          }
        }
      },
      "gt0007": {
        "id": "gt0007",
        "model_id": "openEHR-EHR-OBSERVATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "template_id": "openEHR-EHR-OBSERVATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "type": "INPUT",
        "elements": {
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          }
        }
      },
      "gt0012": {
        "id": "gt0012",
        "model_id": "openEHR-EHR-OBSERVATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "template_id": "openEHR-EHR-OBSERVATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          }
        }
      },
      "gt0015": {
        "id": "gt0015",
        "model_id": "openEHR-EHR-EVALUATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "template_id": "openEHR-EHR-EVALUATION.international_prognostic_index_for_diffuse_large_b_cell_lymphoma_ipi_and_r_ipi.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/items[at0002]"
          },
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/items[at0003]"
          },
          "gt0018": {
            "id": "gt0018",
            "path": "/data[at0001]/items[at0004]"
          },
          "gt0019": {
            "id": "gt0019",
            "path": "/data[at0001]/items[at0005]"
          },
          "gt0020": {
            "id": "gt0020",
            "path": "/data[at0001]/items[at0006]"
          },
          "gt0021": {
            "id": "gt0021",
            "path": "/data[at0001]/items[at0007]"
          }
        }
      }
    },
    "rules": {
      "gt0022": {
        "id": "gt0022",
        "priority": 10,
        "when": [
          "$gt0003|Age|>60,a"
        ],
        "then": [
          "$gt0013|Age|=1|local::at0006|>60|"
        ]
      },
      "gt0023": {
        "id": "gt0023",
        "priority": 9,
        "when": [
          "$gt0003|Age|<=60,a"
        ],
        "then": [
          "$gt0013|Age|=0|local::at0005|<=60|"
        ]
      },
      "gt0024": {
        "id": "gt0024",
        "priority": 8,
        "when": [
          "$gt0008|Ann Arbor stage III-IV (III-Involvement on both sides of the diaphragm, IV-Involvement of extranodal sites)|!=null",
          "$gt0009|ECOG performance status ≥2|!=null",
          "$gt0010|Serum LDH level >1× normal|!=null",
          "$gt0011|>1 extranodal site (Bone marrow, GI tract, liver, lung, CNS, skin, testes, Waldeyer’s ring)|!=null"
        ],
        "then": [
          "$gt0014|Points|.magnitude=$gt0013.value+$gt0008.value+$gt0009.value+$gt0010.value+$gt0011.value"
        ]
      },
      "gt0025": {
        "id": "gt0025",
        "priority": 7,
        "when": [
          "$gt0014|Points|==0"
        ],
        "then": [
          "$gt0016|R-IPI Prognosis|='Very good'",
          "$gt0017|R-IPI 4-year overall survival|='94 %'",
          "$gt0018|R-IPI 4-year progression-free survival|='94 %'",
          "$gt0019|IPI Risk group|='Constant value'"
        ]
      },
      "gt0026": {
        "id": "gt0026",
        "priority": 6,
        "when": [
          "$gt0014|Points|>=1",
          "$gt0014|Points|<=2"
        ],
        "then": [
          "$gt0016|R-IPI Prognosis|='Good'",
          "$gt0017|R-IPI 4-year overall survival|='79 %'",
          "$gt0018|R-IPI 4-year progression-free survival|='80 %'"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 5,
        "when": [
          "$gt0014|Points|>=3",
          "$gt0014|Points|<=5"
        ],
        "then": [
          "$gt0016|R-IPI Prognosis|='Poor'",
          "$gt0017|R-IPI 4-year overall survival|='55 %'",
          "$gt0018|R-IPI 4-year progression-free survival|='53 %'"
        ]
      },
      "gt0029": {
        "id": "gt0029",
        "priority": 4,
        "when": [
          "$gt0014|Points|>=0",
          "$gt0014|Points|<=1"
        ],
        "then": [
          "$gt0019|IPI Risk group|='Low'",
          "$gt0020|IPI 4-year overall survival|='82 %'",
          "$gt0021|IPI 4-year progression-free survival|='85 %'"
        ]
      },
      "gt0030": {
        "id": "gt0030",
        "priority": 3,
        "when": [
          "$gt0014|Points|==2"
        ],
        "then": [
          "$gt0019|IPI Risk group|='Low-intermediate'",
          "$gt0020|IPI 4-year overall survival|='81 %'",
          "$gt0021|IPI 4-year progression-free survival|='80 %'"
        ]
      },
      "gt0031": {
        "id": "gt0031",
        "priority": 2,
        "when": [
          "$gt0014|Points|==3"
        ],
        "then": [
          "$gt0019|IPI Risk group|='High-intermediate'",
          "$gt0020|IPI 4-year overall survival|='49 %'",
          "$gt0021|IPI 4-year progression-free survival|='57 %'"
        ]
      },
      "gt0032": {
        "id": "gt0032",
        "priority": 1,
        "when": [
          "$gt0014|Points|>=4",
          "$gt0014|Points|<=5"
        ],
        "then": [
          "$gt0019|IPI Risk group|='High'",
          "$gt0020|IPI 4-year overall survival|='59 %'",
          "$gt0021|IPI 4-year progression-free survival|='51 %'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)",
            "description": "The International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI) estimates 4-year progression-free survival and 4-year overall survival for patients with diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL)."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Age",
            "description": "Age in years, and for babies: months, weeks or days"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Ann Arbor stage III-IV (III-Involvement on both sides of the diaphragm, IV-Involvement of extranodal sites)",
            "description": "III: Involvement on both sides of the diaphragm, IV: Involvement of extranodal sites"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "ECOG performance status ≥2",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Serum LDH level >1× normal",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": ">1 extranodal site (Bone marrow, GI tract, liver, lung, CNS, skin, testes, Waldeyer’s ring)",
            "description": "Bone marrow, GI tract, liver, lung, CNS, skin, testes, Waldeyer’s ring"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Age",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Points",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "R-IPI Prognosis",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "R-IPI 4-year overall survival",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "R-IPI 4-year progression-free survival",
            "description": "*"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "IPI Risk group",
            "description": "*"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "IPI 4-year overall survival",
            "description": "*"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "IPI 4-year progression-free survival",
            "description": "*"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Set Age>60 years to 1"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Set Age<= 60 years to 0"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Set IPI/R-IPI score"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Set R-IPI interpretation to Very good"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Set R-IPI interpretation to Good"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Set R-IPI interpretation to Poor"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Set IPI interpretation to Low"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Set IPI interpretation to Low-intermediate"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Set IPI interpretation to High-intermediate"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Set IPI interpretation to High"
          }
        }
      }
    }
  }
}